Humana EBITDA 2010-2024 | HUM | MacroTrends

Humana EBITDA 2010-2024 | HUM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Humana EBITDA for the quarter ending December 31, 2024 was $-0.303B, a 175.45% increase year-over-year.

Humana 2024 EBITDA was 3.53B, a 28.4% decline from 2023.
Humana 2023 EBITDA was 4.93B, a 6.14% increase from 2022.
Humana 2022 EBITDA was 4.645B, a 20.31% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Humana EBITDA 2010-2024 | HUM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Humana 2024 EBITDA was 3.53B, a 28.4% decline from 2023.
Humana 2023 EBITDA was 4.93B, a 6.14% increase from 2022.
Humana 2022 EBITDA was 4.645B, a 20.31% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
UnitedHealth Group (UNH)	$470.3B
Cigna Group (CI)	$82.7B
Centene (CNC)	$28.6B
Molina Healthcare (MOH)	$15.9B
Select Medical Holdings (SEM)	$2.5B
Joint (JYNT)	$172M
Aethlon Medical (AEMD)	$9M